nimacimab glp-1 news Is The SKYE The Limit on This CB1 Weight Loss Molecule? SKYE BIOSCIENCES (SKYE-NASD) FDA approves first GLP-1 pill

The FDA cannot verify the quality, safety, or effectiveness of these non-FDA-approved compounded GLP-1 products Entities engaged in mass marketing should be on notice. FDA Press Announcement In regulatory language, the agency also made clear that compounded products cannot be marketed as generic, clinically proven, or equivalent to approved drugs

GLP-1 Injections A GLP-1 injection is often used to help manage type 2 diabetes and can lead to more manageable weight loss

The symptoms kept shifting, but the discomfort stayed the same, and the anxiety followed quickly

They make food fuel, and many people think they want this

Chintan Dave explicitly emphasizes that because this is a registry-based observational study, it demonstrates a clear statistical association but does not prove direct cause-and-effect

The findings emphasise the urgent need for gender-sensitive diagnostic frameworks, enhanced professional training, and a person-centred approach to care. The specific perimenopause connection is this: researchers are increasingly exploring how ADHD and autism present differently in women, including the role of masking behaviours and hormonal fluctuations, and recent studies have shown that autistic people and ADHDers may be particularly vulnerable to difficulties during menopause